Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles